483 Roundup: FDA Finds Faults During On-Site Inspections

Drug GMP Report
A A
Problems with handling complaints, maintaining sterile production conditions and following up on testing crop up in reports of on-site inspections.

To View This Article:

Login

Subscribe To Drug GMP Report